The topics include the discussion of the applications in relation to metabonomics and gut microbiota in nutritional research, in dysbiosis obesity and disease and a review of future therapeutical, nutraceutical and clinical applications.
It also examines the translatability of systems biology approaches into applied clinical research and to patient health and nutrition. The rise in multifactorial disorders, the lack of understanding of the molecular processes at play and the needs for dysbiosis obesity prediction in asymptomatic conditions are some of the many questions that system biology dysbiosis obesity are cancer endometrial nccn suited to address.
Achieving this goal lies in our ability to model and understand the complex web of interactions between genetics, metabolism, environmental factors and gut microbiota. Being the most densely populated microbial ecosystem on earth, gut microbiota co-evolved as a key component of human biology, essentially extending the physiological definition of humans.
Major advances in microbiome research have shown that the contribution of the intestinal microbiota to the overall health status of the host has been dysbiosis obesity far underestimated. In many aspects, humans are not a complete and fully healthy organism without their appropriate microbiological components.
Increasingly, scientific evidence identifies gut microbiota as a key biological interface between human genetics and environmental conditions encompassing nutrition. Microbiota dysbiosis or variation in metabolic activity has been associated with metabolic deregulation e. Metabonomics and Gut Microbiota in Nutrition and Disease serves as a handbook for postgraduate students, researchers in life sciences or health sciences, scientists in academic and industrial environments working in application areas as diverse as health, disease, nutrition, microbial research and dysbiosis obesity clinical medicine.